A Study of EMB-09 in Participants With Advanced or Metastatic Solid Tumors.

NCT05263180 · clinicaltrials.gov ↗
PHASE1
Phase
UNKNOWN
Status
30
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Shanghai EpimAb Biotherapeutics Co., Ltd.